July 11, 2020

CLINICAL UPDATES

What has been the telemedicine experience in urology during the COVID-19 pandemic?

3 urologists discuss their experience with telemedicine during the COVID-19 pandemic.

Cabozantinib shows intriguing activity in heavily pretreated urothelial carcinoma

Cabozantinib's single-agent activity opens the potential for combination approaches with immunotherapy.

Want the latest in urology, but no time to read? Check out our new podcast, “Speaking of Urology” to get expert clinical analysis, practice advice, and policy perspectives, all in a convenient virtual format. Listen now!